Equity (Details) - USD ($)		1 Months Ended		3 Months Ended
	Jun. 29, 2023	Oct. 18, 2022	Sep. 22, 2022	Mar. 31, 2023	Dec. 31, 2022
Equity (Details) [Line Items]
Capital stock conversion description				On September 22, 2022, the Company’s stockholders voted to approve an amendment to the Articles of Incorporation to increase the total number of authorized shares of the Company’s capital stock from 510,000,000 shares, par value $0.00001 per share, to 3,010,000,000 shares, of which 3,000,000,000 shares will be designated as common stock and 10,000,000 shares will be designated as preferred stock, in accordance with the voting results listed below.
Common stock, shares issued				2,484,501,880	2,484,426,501
Common stock, shares outstanding				2,484,501,880	2,484,426,501
Investors sold aggregate price		500,000,000
Warrants common stock		500,000,000
Common stock acquired warrants		500,000,000
Warrants common stock		500,000,000
Consideration payment (in Dollars)		$ 500,000
Purchase price (in Dollars per share)		$ 0.001		$ 182,000
Common stock warrant price (in Dollars per share)		0.001
Common stock an exercise price (in Dollars per share)		$ 0.001
Common stock percentage				10.00%
Securities purchase agreement percentage				0.16%
Weighted average contractual term				4 years 6 months
Warrants aggregating				12,361,622
Right to receive shares				3,000,000
Restricted common shares				1,100,000
Reverse Split description			On November 1, 2022, the Board of Director’s determined the ratio for the Reverse Split is to be 1,000 for 1, with one share of Common Stock being issued for each 1,000 shares of Common Stock issued and outstanding, with any fractional shares of Common Stock resulting therefrom being rounded up to the nearest whole share of Common Stock. The company has submitted the reverse stock split plan for review to FINRA on November 4, 2022.
Subsequent Event [Member]
Equity (Details) [Line Items]
Common stock, shares issued	319,000,000
Additional common stock shares	319,000,000